VJHemOnc is committed to improving our service to you

ISA 2020 | Waldenstrom’s macroglobulinemia in the era of immunotherapy

VJHemOnc is committed to improving our service to you

Morie Gertz

Waldenström macroglobulinemia is a rare hematological cancer characterized by an excess of abnormal lymphoplasmacytic cells in the bone marrow and is classified as a lymphoplasmacytic lymphoma. Morie Gertz, MD, MACP, Mayo Clinic, Rochester, MN, discusses the treatment of Waldenstrom’s macroglobulinemia in the era of immunotherapy. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter